🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,063 results for “BRIGHT MINDS BIOSCIENCES INC.” Clear

  1. varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Alcoholism

    phase 2 small molecule completed

    1 trial

  2. widow spider antivenom

    BRIGHT MINDS BIOSCIENCES INC.

    Arachnidism

    phase 2 mab completed

    1 trial

  3. xue-fu-zhu-yu capsule

    BRIGHT MINDS BIOSCIENCES INC.

    Qi Stagnation and Blood Stasis Syndrome

    phase 2 small molecule completed

    1 trial

  4. zonisamide

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial

  5. 1 Nalmefene implant

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Abuse and Addiction

    phase 1 small molecule active

    1 trial

  6. 11C-OMAR

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use Disorder

    phase 1 small molecule completed

    1 trial

  7. 124I-labeled monoclonal antibody Mu 11-1F4

    BRIGHT MINDS BIOSCIENCES INC.

    AL Amyloidosis

    phase 1 mab completed

    1 trial

  8. 15-Valent Pneumococcal Conjugate Vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    Pneumonia, Pneumococcal

    phase 1 mab active

    1 trial

  9. 2-4 of the drugs listed below

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    phase 1 small molecule completed

    1 trial

  10. 2-4 of the drugs listed below

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Dependence

    phase 1 small molecule completed

    1 trial

  11. 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Abuse

    phase 1 small molecule terminated

    1 trial

  12. 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fed condition

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Abuse

    phase 1 small molecule terminated

    1 trial

  13. 400 mg Cannabidiol

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 1 small molecule active

    1 trial

  14. AAV8-hCocH

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence, in Remission

    phase 1 small molecule active

    1 trial

  15. AFQ056

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule terminated

    1 trial

  16. ALKS 33-BUP

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Abuse

    phase 1 small molecule completed

    1 trial

  17. APR002

    BRIGHT MINDS BIOSCIENCES INC.

    COVID-19

    phase 1 small molecule completed

    1 trial

  18. ARISE with AR

    BRIGHT MINDS BIOSCIENCES INC.

    Pediatric Cancer

    phase 1 other active

    1 trial

  19. ART-I02

    BRIGHT MINDS BIOSCIENCES INC.

    Arthritis, Rheumatoid

    phase 1 gene therapy active

    1 trial

  20. ASP8062

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 small molecule completed

    1 trial

  21. ASP8082

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 small molecule completed

    1 trial

  22. ATAFENOVIR 200 MG KAPSUL

    BRIGHT MINDS BIOSCIENCES INC.

    Bioequivalence

    phase 1 small molecule active

    1 trial

  23. ATI-1013 (0.2 g)

    BRIGHT MINDS BIOSCIENCES INC.

    Thromboangiitis Obliterans (Buerger's Disease)

    phase 1 mab active

    1 trial

  24. AV-101

    BRIGHT MINDS BIOSCIENCES INC.

    Neuropathic Pain

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources